Antimicrobial Resistance

The Russian invasion of Ukraine represents the largest humanitarian crisis that Europe has faced in decades. In the first 4 months of the war, over 9.9 million refugees crossed the Ukrainian border, and over 6.1 million Ukrainian refugees were registered across Europe.1 Before the war, Ukraine had a high prevalence of tuberculosis (TB); the prevalence of […]

Nosocomial infections are infections that develop when receiving healthcare, usually via invasive procedures, improper infection control or overuse of antibiotics. They pose an increased threat with the rise of antimicrobial resistance in the healthcare setting. It was a pleasure to talk to Dr. Alex Soriano (University of Barcelona, Barcelona, Spain) around his highlights from ECCMID, […]

National Action Plans (NAPs) for antimicrobial resistance (AMR) are crucial in reducing the impact of antimicrobial resistance on global health. They are crucial in addressing this threat by providing a coordinated approach to reducing the emergence and spread of AMR. Dr Esmita Charani (Centre of Excellence Infectious Diseases Research, University of Liverpool, Liverpool, UK) joins […]

Antibiotic shortages continue to be a significant challenge in healthcare systems around the world, with a huge need for global action to address this public health issue. Dr Esmita Charani (Centre of Excellence Infectious Diseases Research, University of Liverpool, Liverpool, UK) joins us to discuss the current state of antibiotic shortages in healthcare systems, the […]

Multidrug resistance (MDR) is a significant public health concern, leading to increased  hospital stays, higher healthcare costs, and increased mortality rates. The overuse and misuse of antibiotics are major contributors to the development of MDR.  We met with Dr Grace Salazar Tamayo (Hospital General Dr Manuel Gea González, Mexico City, Mexico) to discuss a retrospective […]

With drug-resistant bacteria classified as an increasing threat globally by the WHO, there is an increasing need for the development of new antibiotics. Nineteen gold-based antibiotics were recently studied against a range of multidrug-resistant bacteria. In this interview, Dr. Sara Soto González (University of Barcelona, Barcelona, Spain) discusses the rationale for investigating gold(III) metalloantibiotics in […]

Isavuconazole is a once-daily antifungal, used to treat a wide array of fungal infections. In this touchINFECTIOUS DISEASES interview, we met with Prof. Kayla Stover Hielscher (University of Mississippi School of Pharmacy, Jackson, MS, USA) to discuss isavuconazole’s properties and the efficacy and safety compared to other treatment options. The abstract entitled: ‘This Drug for […]

Ceftriaxone is frequently used to treat methicillin-susceptible Staphylococcus aureus (MSSA). In this touchINFECTIOUS DISEASES interview, we met with Prof. Kayla Stover Hielscher (University of Mississippi School of Pharmacy, Jackson, MS, USA) to discuss advantages and limitations of the use of ceftriaxone for the treatment of MSSA, and the data that exists to support its use […]

Methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia is one of the more severe forms of MRSA. In this touchINFECTIOUS DISEASES interview, we met with Prof. Kayla Stover Hielscher (University of Mississippi School of Pharmacy, Jackson, MS, USA) to discuss the use of linezolid as a treatment option for MRSA bacteraemia infection. Dr Stover Hielscher discusses drug interactions, […]